Citation Impact
Citing Papers
Critical challenges and emerging opportunities in hepatitis C virus research in an era of potent antiviral therapy: Considerations for scientists and funding agencies
2018 StandoutNobel
Genetic variation inCLDN1and susceptibility to hepatitis C virus infection
2009 StandoutNobel
Immune modulation to prevent antibody-mediated rejection after allogeneic hematopoietic stem cell transplantation
2011
Guidelines on the use of therapeutic apheresis in clinical practice—Evidence‐based approach from the apheresis applications committee of the American Society for Apheresis
2010
Comparative Outcome Analysis of ABO-Incompatible and Positive Crossmatch Renal Transplantation: A Single-Center Experience
2009
Clinical epidemiology of human AE in Europe
2015
Kidney transplantation across HLA and ABO antibody barriers
2013
Regulation of chromatin by histone modifications
2011 Standout
Prospects for prophylactic and therapeutic vaccines against the hepatitis C viruses
2010 StandoutNobel
Ex Vivo Liver Resection and Autotransplantation for End-Stage Alveolar Echinococcosis: A Case Series
2015
Deletion of Fibrinogen-like Protein 2 (FGL-2), a Novel CD4+ CD25+ Treg Effector Molecule, Leads to Improved Control of Echinococcus multilocularis Infection in Mice
2015
Global Distribution of Alveolar and Cystic Echinococcosis
2017 Standout
Hepatitis C virus envelope glycoprotein immunization of rodents elicits cross-reactive neutralizing antibodies
2007 StandoutNobel
The Hepatitis C Virus Non-structural NS5A Protein Impairs Both the Innate and Adaptive Hepatic Immune Response in Vivo
2009
Diagnostic Tools for Monitoring Kidney Transplant Recipients
2007
Hepatitis C virus entry: Molecular biology and clinical implications
2006
Chronic hepatitis C virus infection and pathogenesis of hepatocellular carcinoma
2016
Cellular and molecular mechanisms of renal fibrosis
2011 Standout
Therapeutic apheresis in kidney AB0 incompatible transplantation
2017
Red blood cell-incompatible allogeneic hematopoietic progenitor cell transplantation
2011
Early Experience of Paired Living Kidney Donation in the United Kingdom
2008
Platelet Activation and Atherothrombosis
2007 Standout
Interferon Lambda Alleles Predict Innate Antiviral Immune Responses and Hepatitis C Virus Permissiveness
2014 StandoutNobel
Cell culture–produced hepatitis C virus does not infect peripheral blood mononuclear cells
2008 StandoutNobel
Outcome of ABO-Incompatible Living Donor Renal Transplantations: A Single-Center Experience From Eastern India
2016
The Echinococcoses
2017
Early Clinical Complications After ABO-Incompatible Live-Donor Kidney Transplantation
2014
Clinical Guide to ABO-Incompatible Allogeneic Stem Cell Transplantation
2013
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010
2011 Standout
Current techniques for AB0-incompatible living donor liver transplantation
2016
Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry
2007 StandoutNatureNobel
ABO Incompatible Renal Transplantation Without Antibody Removal Using Conventional Immunosuppression Alone
2014
Hepatitis C Virus: 30 Years after Its Discovery
2019 StandoutNobel
ABO Antibody Titer and Risk of Antibody‐Mediated Rejection in ABO‐Incompatible Renal Transplantation
2010
Platelet genomics and proteomics in human health and disease
2005
The HCV Life Cycle: In vitro Tissue Culture Systems and Therapeutic Targets
2014 Standout
A Hepatitis C Virus (HCV) Vaccine Comprising Envelope Glycoproteins gpE1/gpE2 Derived from a Single Isolate Elicits Broad Cross-Genotype Neutralizing Antibodies in Humans
2013 StandoutNobel
ABO-Incompatible Matching Significantly Enhances Transplant Rates in Kidney Paired Donation
2013
Principles of Separation
2013
Guidelines on the use of therapeutic apheresis in clinical practice—Evidence‐based approach from the apheresis applications committee of the American society for apheresis
2007
Development of Virus-Like Particle Technology from Small Highly Symmetric to Large Complex Virus-Like Particle Structures
2013 Standout
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Induction of Broad CD4+and CD8+T-Cell Responses and Cross- Neutralizing Antibodies against Hepatitis C Virus by Vaccination with Th1-Adjuvanted Polypeptides Followed by Defective Alphaviral Particles Expressing Envelope Glycoproteins gpE1 and gpE2 and Nonstructural Proteins 3, 4, and 5
2008 StandoutNobel
Structure and Function of the Hepatitis C Virus Envelope Glycoproteins E1 and E2: Antiviral and Vaccine Targets
2016 StandoutNobel
Cascade plasmapheresis as preconditioning regimen for ABO‐incompatible renal transplantation: a single‐center experience
2015
Recombinant Hepatitis C Virus Envelope Glycoprotein Vaccine Elicits Antibodies Targeting Multiple Epitopes on the Envelope Glycoproteins Associated with Broad Cross-Neutralization
2014 StandoutNobel
Therapeutic apheresis in kidney transplantation: A review of renal transplant immunobiology and current interventions with apheresis medicine
2013
Infrared thermography (IRT) applications for building diagnostics: A review
2014 Standout
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
2009 Standout
Broadly Neutralizing Immune Responses against Hepatitis C Virus Induced by Vectored Measles Viruses and a Recombinant Envelope Protein Booster
2012 StandoutNobel
Echinococcosis: Advances in the 21st Century
2019 Standout
Broadly neutralizing antibodies abrogate established hepatitis C virus infection
2014 StandoutNobel
Gene Expression Profiling Indicates the Roles of Host Oxidative Stress, Apoptosis, Lipid Metabolism, and Intracellular Transport Genes in the Replication of Hepatitis C Virus
2010
Rapid induction of virus-neutralizing antibodies and viral clearance in a single-source outbreak of hepatitis C
2007
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice—Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Sixth Special Issue
2013
Progress towards a hepatitis C virus vaccine
2013 StandoutNobel
Kidney paired donation
2011 StandoutNobel
Viral persistence, liver disease, and host response in a hepatitis C–like virus rat model
2017 StandoutNobel
Native Folding of a Recombinant gpE1/gpE2 Heterodimer Vaccine Antigen from a Precursor Protein Fused with Fc IgG
2016 StandoutNobel
Role of the E2 Hypervariable Region (HVR1) in the Immunogenicity of a Recombinant Hepatitis C Virus Vaccine
2018 StandoutNobel
Epithelial-to-mesenchymal transition in cyst lining epithelial cells in an orthologous PCK rat model of autosomal-recessive polycystic kidney disease
2010
Mutations in Hepatitis C Virus E2 Located outside the CD81 Binding Sites Lead to Escape from Broadly Neutralizing Antibodies but Compromise Virus Infectivity
2009 StandoutNobel
The Myeloproliferative Disorders
2006
Hematological Problems in Pediatric Intensive Care
2013 Standout
Works of Jochen Wilpert being referenced
Gene profiling of polycystic kidneys
2006
Rapidly progressive hepatic alveolar echinococcosis in an ABO‐incompatible renal transplant recipient
2010
ABO-Incompatible Kidney Transplantation with Antigen-Specific Immunoadsorption and Rituximab – Insights and Uncertainties
2008
Gene expression profiling in polycythaemia vera: overexpression of transcription factor NF‐E2
2005
ABO‐incompatible kidney transplantation using antigen‐specific immunoadsorption and rituximab: a single center experience
2006
Host cell responses induced by hepatitis C virus binding†
2006
Comparing the Tube and Gel Techniques for ABO Antibody Titration, as Performed in Three European Centers
2007
Implementation of a Protocol for ABO-Incompatible Kidney Transplantation – A Three-Center Experience With 60 Consecutive Transplantations
2007
Long-term outcome of ABO-incompatible living donor kidney transplantation based on antigen-specific desensitization. An observational comparative analysis
2010
On-demand strategy as an alternative to conventionally scheduled post-transplant immunoadsorptions after ABO-incompatible kidney transplantation
2007
Expression profiling on chronically rejected transplant kidneys1
2003
Preemptive Postoperative Antigen-Specific Immunoadsorption in ABO-Incompatible Kidney Transplantation: Necessary or Not?
2007